Recruitment to Kyntheum (brodalumab), Cimzia (certolizumab pegol), and Skilarence (dimethyl fumarate) has now ended. Patients who were consented and started these treatments before the 1st August must be added to the database before 21st August. Recruitment is...
Category: News
BADBIR Team at the BDNG 31st Annual Conference
The BADBIR team will be present in Harrogate for the BDNG Annual Conference 20th - 22nd September.We hope to see you there! Related Contact Us Tel: +44 (0)161 306 1896 Email: badbir@manchester.ac.uk Find Us The University of...
BADBIR Team at the July 2022 BAD Annual Meeting
The BADBIR team will be present in Glasgow for the 2022 BAD Annual Meeting 5th - 7th July.We will have a stand in the exhibition hall plus presentations in the morning Medical Dermatology session (Effect modification of biologic survival by patient characteristics)...


Recent Comments